Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity
This study has been completed.
Study NCT00197249
Information provided by GlaxoSmithKline
First Received on September 15, 2005.
Last Updated on November 17, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
